2021 MIPS Measure #476: International Prostate Symptom Score (IPSS) or American Urological Association-Symptom Index (AUA-SI) Change 6-12 Months After Diagnosis of Benign Prostatic Hyperplasia 

Measure Type High Priority Measure? Collection Type(s)
Patient Reported Outcome yes eCQM


Measure Description

Percentage of patients with an office visit within the measurement period and with a new diagnosis of clinically significant Benign Prostatic Hyperplasia who have International Prostate Symptoms Score (IPSS) or American Urological Association (AUA) Symptom Index (SI) documented at time of diagnosis and again 6-12 months later with an improvement of 3 points.


CMS-Family-Medicine-2021, CMS-Geriatrics-2021, CMS-Infectious-Disease-2021, CMS-Internal-Medicine-2021, CMS-Obstetrics-Gynecology-2021, CMS-Preventive-Medicine-2021, CMS-Urology-2021, Internal Medicine, Obstetrics/Gynecology, Preventive Medicine, Quality-2021